Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
environment where open dialogue between people with different backgrounds and perspectives lay the foundation for learning, creativity and development. We welcome people with different backgrounds and
-
of the biology that underlies cancer initiation, progression and metastatic dissemination with the ultimate goal to develop more effective and specific anti-cancer (combination) therapies. CCB is currently
-
collaboration and cooperation - intra-institute, national and international, interdisciplinary opportunities to develop – on the job and towards other positions an international environment – everyday contact
-
funds for scientific travel Opportunity for professional development including co-supervisory experience Flexible working conditions Attractive benefits incl. subsidy for public transport across Germany
-
, visualization, and development of new computational methods for processing and analysis of large-scale omics data. We welcome applications from candidates with pure computational background and those combining
-
of longitudinal cognitive data. Within this group led by Dr. Luca Kleineidam, the applicant will work on challenging and rewarding projects in a friendly and supportive team. Your tasks: Conduct and development
-
to define how RecQ helicases maintain genome stability to limit premature aging and cancer development. These projects will benefit from access to cutting-edge mass spectrometry, imaging, screening and
-
phenological data using camera and drone-based imagery. Use genetic analyses to assess the relationship between genetic differentiation and phenological variation. Develop and implement advanced statistical
-
development, translational medicine, bioinformatics&data mining, and AI-enabled biomedical engineering. As a faculty member at SUSTech, you will have the opportunity to shape the future of your career while
-
both in vivo and in vitro, sequenced the genome of the Iberian newt, established stable transgenesis, and created genome-edited newts. Harnessing these technological developments, the group is combining